CausalSentinel

Protein Dossier — MMP7 (Matrilysin)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: R55 Syncope and collapse 0.179 0.0662 0.00688 Wald ratio 1 cis NA
Non-cancer illness code self-reported: osteoarthritis 0.0604 0.0234 0.00987 Wald ratio 1 cis NA
Diagnoses - main ICD10: N40 Hyperplasia of prostate 0.163 0.066 0.0137 Wald ratio 1 cis NA
Non-cancer illness code self-reported: chronic obstructive airways disease or copd 0.233 0.102 0.0223 Wald ratio 1 cis NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast 0.114 0.0519 0.0287 Wald ratio 1 cis NA
Non-cancer illness code self-reported: mania or bipolar disorder or manic depression 0.242 0.116 0.0369 Wald ratio 1 cis NA
Vascular or heart problems diagnosed by doctor: Angina 0.0793 0.0385 0.0395 Wald ratio 1 cis NA
Non-cancer illness code self-reported: bone disorder 0.245 0.126 0.0521 Wald ratio 1 cis NA
Non-cancer illness code self-reported: polio or poliomyelitis 0.39 0.202 0.0527 Wald ratio 1 cis NA
Neo-openness to experience -0.482 0.257 0.0609 Wald ratio 1 cis NA
Birth weight 0.0216 0.0117 0.0649 Wald ratio 1 cis NA
Clear cell ovarian cancer 0.222 0.123 0.072 Wald ratio 1 cis NA
…and 94 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2789_26_2 MMP-7 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

78 association rows across 31 traits (68 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating MMP7 levels (id: OID00441_OID20087) 4e-661 rs11568819 5 GCST90859801 no MR -> candidate analysis
Circulating MMP7 levels (id: OID00814_OID20087) 3e-387 rs11568819 6 GCST90860144 no MR -> candidate analysis
Matrilysin (analyte X2789.26) levels 2e-278 rs11568819 1 GCST90425473 no MR -> candidate analysis
Cerebrospinal fluid protein MMP7 levels 1e-232 rs11568819 1 GCST90944433 no MR -> candidate analysis
Matrix metalloproteinase-7 levels 2e-222 rs11568819 6 GCST90012056 no MR -> candidate analysis
Matrilysin levels 2e-139 rs11568819 7 GCST90248425 no MR -> candidate analysis
MMP7 protein levels 6e-112 rs7946641 3 GCST90469921 no MR -> candidate analysis
MMP10 protein levels 4e-111 rs184354018 3 GCST90469915 no MR -> candidate analysis
Prostate-specific antigen levels 3e-82 rs11568818 5 GCST90461907 no MR -> candidate analysis
prostate-specific antigen (PSA, minimum, inv-norm transforme 2e-49 rs11568818 2 GCST90476322 no MR -> candidate analysis
Serum levels of protein MMP7 6e-42 rs11568819 1 GCST90088072 no MR -> candidate analysis
prostate-specific antigen (PSA, mean, inv-norm transformed) 1e-39 rs11568818 2 GCST90476319 no MR -> candidate analysis
…and 19 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1135 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
prostate carcinoma 0.745 common-variant locus no MR -> candidate analysis
prostate cancer 0.663 common-variant locus no MR -> candidate analysis

Of the 2 rows above, 2 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 4 known modulators (Matrilysin)
gnomAD constraint pLI=3.9e-08, LOEUF=1.15 — LoF-tolerant
GWAS Catalog 65 unique SNPs / 129 rows
ClinVar 75 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance